Status:
UNKNOWN
Antigen-specific Immune Response to Hepatitis B Virus in Utero
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Hepatitis B
Eligibility:
FEMALE
21-45 years
Brief Summary
This study aims to gain an understanding of the key components of the immune response to hepatitis B present in cord blood of HBV infected mothers.
Detailed Description
Despite the development of an effective preventive HBV vaccine, the spread of HBV virus continue, particularly in Asia, where the majority of HBV infection is acquired at birth by vertical transmissio...
Eligibility Criteria
Inclusion
- Pregnant women with HBsAg+
Exclusion
- Pregnant women without HBsAg+
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00845403
Start Date
September 1 2008
End Date
December 1 2016
Last Update
January 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore, 119074